Skip to content
  • Sunday, 23 August 2026
  • 2:29 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 26, 2026 0

Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 17, 2026 0

Traumatic brain injury (TBI) represents a formidable global public health challenge, impacting an estimated 69 million individuals each year across…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha May 30, 2026 0

Traumatic brain injury (TBI) stands as a profound and pervasive global health crisis, impacting an estimated 69 million individuals each…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha May 23, 2026 0

Traumatic Brain Injury (TBI) stands as a formidable global public health crisis, impacting an estimated 69 million individuals annually across…

Read More
Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025The Court Said Talk Therapy Is Protected Speech, Not Medical ConductThe Atomic Gap Challenge: How Interface Physics May Determine the Future of 2D Semiconductor TechnologyCan the heart heal itself? New study says it can
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ